找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Evidence-based Therapy in Vascular Surgery; E. Sebastian Debus,Reinhart T. Grundmann Book 20171st edition The Editor(s) (if applicable) an

[復(fù)制鏈接]
樓主: 變更
11#
發(fā)表于 2025-3-23 11:50:19 | 只看該作者
12#
發(fā)表于 2025-3-23 14:08:34 | 只看該作者
13#
發(fā)表于 2025-3-23 19:01:10 | 只看該作者
14#
發(fā)表于 2025-3-23 23:11:04 | 只看該作者
https://doi.org/10.1007/978-981-13-8149-2e are no evidence-based recommendations showing that one method is more advantageous than the other. The type of revascularization must be chosen with regard to patient comorbidity, degree of ulceration, extent of the arterial lesion, and available expertise of the center. Diabetic foot osteomyeliti
15#
發(fā)表于 2025-3-24 03:43:01 | 只看該作者
Andrzej Zi?bik,Krzysztof Hoinka be considered as an alternative to CEA in high-volume centres with documented death or stroke rate <3% in asymptomatic patients, and <6% in symptomatic patients, respectively. Especially, women younger than 75 years of age, patients with contralateral occlusion and restenosis have no increased risk with CAS compared to CEA.
16#
發(fā)表于 2025-3-24 07:08:40 | 只看該作者
https://doi.org/10.1007/978-3-319-48220-0are outlined. For the uncomplicated forms a conservative approach is recommended, complicated forms require endovascular stent grafting or an open surgical procedure. Although randomized studies are missing, the results of retrospective case series and register-related studies favor the endovascular treatment over open surgery.
17#
發(fā)表于 2025-3-24 11:56:55 | 只看該作者
18#
發(fā)表于 2025-3-24 16:29:07 | 只看該作者
19#
發(fā)表于 2025-3-24 20:02:02 | 只看該作者
André Dorsman,Wim Westerman,John L. Simpson Renal artery angioplasty and stenting may be considered for patients with RAS and complicated, uncontrolled hypertension. Surgery remains the primary approach for patients with complex lesions of arterial bifurcation or branches, stenoses associated with complex aneurysms, or following PTA failure.
20#
發(fā)表于 2025-3-24 23:47:25 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 08:30
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
梨树县| 乌兰浩特市| 清丰县| 鞍山市| 保德县| 个旧市| 峨边| 惠安县| 广南县| 浮梁县| 巴彦县| 阿拉善盟| 宜都市| 甘南县| 天柱县| 吉首市| 大丰市| 布尔津县| 花垣县| 铜鼓县| 甘南县| 涡阳县| 平定县| 汶川县| 奉贤区| 临邑县| 乌拉特中旗| 沙坪坝区| 芦溪县| 新津县| 易门县| 黑山县| 德阳市| 沈丘县| 青河县| 东宁县| 枣庄市| 师宗县| 安化县| 永登县| 保定市|